Completed NA INTERVENTIONAL 4-arm NCT00963040

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

The Effect of Intranasal Oxytocin on Headache Intensity and Headache-associated Symptoms in Patients Suffering From Chronic Daily Headache

Sponsor: MedVadis Research Corporation

Conditions Chronic Daily Headache

Interventions Sterile water Syntocinon

Updated 8 times since 2017 Last updated: Jun 13, 2023 Started: Nov 30, 2009 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Chronic Daily Headache, this trial is completed. The trial is conducted by MedVadis Research Corporation and has accumulated 8 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jul 2023 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MedVadis Research Corporation

Data source: MedVadis Research Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wellesley Hills, United States